Precise Biometrics AB ("Precise") today announces that it has completed a private placement of 22,000,000 new shares, providing the company with approximately SEK 86 million before transaction costs.
The private placement, which was announced on the 5thof September, 2013, has allowed Precise to place 22,000,000 new shares with international intuitional investors and qualified investors in Sweden at a price of SEK 3.90 per share through an accelerated book-building procedure.
The proceeds from the Private Placement will further enhance the company's working capital related to growth and order financing.
"We are excited about the interest shown by investors, both in Sweden and internationally, and welcome them on board as shareholders. The transaction strengthens our financial position and enables the Company to capitalize on the exciting opportunities arising as the market grows and keep up the high tempo in our current expansion", says Thomas Marschall, President and CEO of Precise Biometrics.
For the purpose of the private placement, the Board of Director of Precise has resolved, pursuant to the authorization given by the 2013 annual general meeting, on a directed issue of 22,000,000 new shares. The purpose of the resolution to issue new shares, deviating from the shareholders' preferential rights, is primarily to take advantage of an opportunity to raise capital on advantageous terms from new, from a financial perspective, strategically important owners, thereby promoting Precise's ability to create further value for all shareholders.
The new issue results in an equity dilution of 6.4 based on the number of shares after the new issue. The subscription price has been established through a customary book-building procedure. In relation to the 10 day volume weighted average share price on the 5thof September after market close, the subscription price corresponds to a discount of 8 percent. In relation to the market close price on the 5thof September, the subscription price corresponds to a discount of 9 percent.
Through the issue, the number of shares in Precise increases by 22,000,000 from 323,306,094 shares to a total of 345,306,094 shares and the share capital increases by SEK 6,160,000.00 from SEK 90,525,706.38 to a total of SEK 96,685,706.38
Carnegie Investment Bank served as financial advisor and bookrunner in connection with the directed share issue.
Precise Biometrics AB (publ) may be required to disclose the information provided herein pursuant to the Securities Markets Act. The information was submitted for publication at 08:00am on September 6, 2013.
The publication or distribution of this press release may in certain jurisdictions be subject to restriction by law, and persons in the jurisdictions where this press release has been published or distributed should inform themselves of and follow such legal restrictions. This press release does not contain or constitute an invitation or offer to acquire, subscribe to or otherwise trade with shares, subscription rights or other securities in Precise Biometrics.
This press release may not be made public, published or distributed, either directly or indirectly in the United States, Canada, Japan, New Zealand, South Africa, Australia or any other country where such procedures are subject in full or in part to legal restrictions. Nor may the information in this press release may not be communicated, reproduced or presented in any way that is in conflict with such restrictions. Failure to follow this instruction may involve a breach of the United States Securities Act from 1933 ("Securities Act") or applicable laws in other jurisdictions.
This press release may contain forward-looking statements. When used in this press release, words such as "evaluate", "expect" and "intend" are intended to identify forward-looking statements. They may involve risks and uncertainties, including product demand and market acceptance, the effect of economic conditions, the impact of competitive products and pricing, foreign currency exchange rates and other risks. These forward-looking statements reflect the views of the management as of the date made with respect to future events and are subject to risks and uncertainties. All of these forward-looking statements are based on estimates and assumptions made by the management and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results or experience could differ materially from the forward-looking statements. Precise Biometrics disclaims any intention or obligation to update these forward-looking statements.
FOR FURTHER INFORMATION, PLEASE CONTACT
Thomas Marschall, President and CEO, Precise Biometrics AB
Telephone; +46 46 31 11 10 or +46 734 35 11 10, E-mail; firstname.lastname@example.org
Patrik Norberg, CFO, Precise Biometrics AB
Telephone; +46 46 31 11 47 or +46 734 35 11 47, E-mail; email@example.com
Precise Biometrics is a market-leading provider of solutions for fingerprint recognition to prove people's identities. With top-of-the-line expertise in fingerprint verification, Precise Biometrics offers fast, accurate and secure authentication of a person.
The technology adds value to ID, enterprise and bank cards as well as access to mobile solutions, computers and networks. Precise Biometrics serves business and government organizations throughout the world and its technology is licensed to close to 160 million users.
For more information, please visit www.precisebiometrics.com